26/18. Lustrobopag- (MULTPLETA)-(July 2018)- to treat thrombocytopenia patients
Drug Name:
26/18. Lustrobopag- (MULTPLETA)-(July 2018)- to treat thrombocytopenia patients
List Of Brands:
Indication Type Description:
Indication:
U.S. FDA APPROVED DRUGS DURING 2018
Sr.No- 26
Name of the Drug- MULTIPLETA
Active Ingredient - Lustrobopag
Pharmacological Classification-
To treat thrombocytopenia in adult patients who are scheduled to undeergo a procedure
Date of Approval- July 2018